Profitability Metrics

Gross Margin
99.59%
Operating Margin
28.24%
Net Margin
24.55%

Efficiency Metrics

Revenue per Expense Ratio
3.53
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
72.12%
Income Tax Rate
0.00%
EPS
0.2700000000

Balance Sheet Analysis

Current Ratio
26.12
Cash Ratio
26.12
Working Capital
$12.12M
Debt to Equity
1.09
Debt to Assets
40.24%
Equity Ratio
36.78%

Cash Flow Analysis

Operating Cash Flow Ratio
33.74%
Free Cash Flow Ratio
33.39%
CapEx to Revenue
0.35%
Dividends Paid
$25.73M
Stock Buybacks
$226.33K
Total Shareholder Returns
$25.95M
Cash Position Change
-46.87%

Detailed Growth Metrics

Core Performance

Revenue
17.26%
Net Income
-23.96%
EPS
-40.83%
Operating Income
-57.78%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
279.30%
Operating Cash Flow
153.21%
Free Cash Flow
212.35%

Balance Sheet Health

Assets
1,256.29%
Debt
52,668.83%
Book Value per Share
325.90%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
-2.45%
Shares Outstanding
17.23%

Long Term Trends

3Y Revenue/Share
74.06%
5Y Revenue/Share
94.04%
3Y Dividend/Share
61.51%
5Y Dividend/Share
32.15%